-
Something wrong with this record ?
Giant Bilateral Adrenal Myelolipomas in a Non-Compliant Patient with Congenital Adrenal Hyperplasia
T. Brutvan, O. Psenicka, J. Krizova, M. Kotasova, J. Jezkova
Language English Country United States
Document type Case Reports, Journal Article
NLK
Free Medical Journals
from 2008
PubMed Central
from 2012
Europe PubMed Central
from 2012
Open Access Digital Library
from 2012-01-01
PubMed
38582958
DOI
10.12659/ajcr.943005
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Glucocorticoids therapeutic use MeSH
- Adrenal Hyperplasia, Congenital * complications diagnosis genetics MeSH
- Humans MeSH
- Lipoma * MeSH
- Myelolipoma * diagnosis surgery complications MeSH
- Adrenal Glands MeSH
- Adrenal Gland Neoplasms * complications diagnosis MeSH
- Steroid 21-Hydroxylase genetics MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
BACKGROUND 21-hydroxylase deficiency, an essential enzyme for glucocorticoid and mineralocorticoid synthesis, is the cause of congenital adrenal hyperplasia (CAH) in more than 95% of cases. It is an autosomal recessive disorder encoded by the CYP21A2 gene, categorized into classical forms, which encompass the salt-wasting (SW) and simple virilizing (SV) forms, as well as the nonclassical form (NC). The aim of medical treatment is to replace missing glucocorticoids and, if necessary, mineralocorticoids, while also reducing elevated adrenal androgens. CASE REPORT We present the case of a 42-year-old woman with CAH who discontinued therapy during adolescence and was admitted to hospital with fatigue, nausea, and severe abdominal pain. A CT scan showed an extreme enlargement of the adrenal glands. Laboratory tests revealed elevated levels of 17-hydroxyprogesterone and other adrenal androgens, along with normal plasma metanephrine levels. Decreased morning cortisol levels suggested partial adrenal insufficiency requiring glucocorticoid replacement therapy. Due to the development of several serious complications and clinical deterioration, the multidisciplinary team recommended bilateral removal of masses measuring 300×250×200 mm on the right side and 250×200×200 mm on the left side. Histological and immunochemical examination confirmed the presence of giant myelolipomas with adrenal cortex hyperplasia. CONCLUSIONS Adrenal tumors, particularly myelolipomas, have a higher prevalence in patients with CAH. Our case report provides further evidence of the suspected link between non-compliant CAH therapy and the development of myelolipomas, along with promotion of their pronounced growth.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014354
- 003
- CZ-PrNML
- 005
- 20240905134224.0
- 007
- ta
- 008
- 240725e20240407xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.12659/AJCR.943005 $2 doi
- 035 __
- $a (PubMed)38582958
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brutvan, Tomas $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
- 245 10
- $a Giant Bilateral Adrenal Myelolipomas in a Non-Compliant Patient with Congenital Adrenal Hyperplasia / $c T. Brutvan, O. Psenicka, J. Krizova, M. Kotasova, J. Jezkova
- 520 9_
- $a BACKGROUND 21-hydroxylase deficiency, an essential enzyme for glucocorticoid and mineralocorticoid synthesis, is the cause of congenital adrenal hyperplasia (CAH) in more than 95% of cases. It is an autosomal recessive disorder encoded by the CYP21A2 gene, categorized into classical forms, which encompass the salt-wasting (SW) and simple virilizing (SV) forms, as well as the nonclassical form (NC). The aim of medical treatment is to replace missing glucocorticoids and, if necessary, mineralocorticoids, while also reducing elevated adrenal androgens. CASE REPORT We present the case of a 42-year-old woman with CAH who discontinued therapy during adolescence and was admitted to hospital with fatigue, nausea, and severe abdominal pain. A CT scan showed an extreme enlargement of the adrenal glands. Laboratory tests revealed elevated levels of 17-hydroxyprogesterone and other adrenal androgens, along with normal plasma metanephrine levels. Decreased morning cortisol levels suggested partial adrenal insufficiency requiring glucocorticoid replacement therapy. Due to the development of several serious complications and clinical deterioration, the multidisciplinary team recommended bilateral removal of masses measuring 300×250×200 mm on the right side and 250×200×200 mm on the left side. Histological and immunochemical examination confirmed the presence of giant myelolipomas with adrenal cortex hyperplasia. CONCLUSIONS Adrenal tumors, particularly myelolipomas, have a higher prevalence in patients with CAH. Our case report provides further evidence of the suspected link between non-compliant CAH therapy and the development of myelolipomas, along with promotion of their pronounced growth.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory nadledvin $x komplikace $x diagnóza $7 D000310
- 650 _2
- $a nadledviny $7 D000311
- 650 12
- $a kongenitální adrenální hyperplazie $x komplikace $x diagnóza $x genetika $7 D000312
- 650 _2
- $a glukokortikoidy $x terapeutické užití $7 D005938
- 650 12
- $a lipom $7 D008067
- 650 12
- $a myelolipom $x diagnóza $x chirurgie $x komplikace $7 D018209
- 650 _2
- $a steroid-21-hydroxylasa $x genetika $7 D013255
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Psenicka, Otakar $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
- 700 1_
- $a Krizova, Jarmila $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
- 700 1_
- $a Kotasova, Marcela $u Institute of Clinical Biochemistry and Laboratory Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
- 700 1_
- $a Jezkova, Jana $u 3rd Department of Internal Medicine, General University Hospital in Prague and the 1st Faculty of Medicine of the Charles University, Prague, Czech Republic
- 773 0_
- $w MED00183037 $t The American journal of case reports $x 1941-5923 $g Roč. 25 (20240407), s. e943005
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38582958 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134218 $b ABA008
- 999 __
- $a ok $b bmc $g 2143870 $s 1226220
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 25 $c - $d e943005 $e 20240407 $i 1941-5923 $m The American journal of case reports $n Am J Case Rep $x MED00183037
- LZP __
- $a Pubmed-20240725